Sol-Gel Technologies (SLGL) Non-Current Assets (2016 - 2026)

Sol-Gel Technologies (SLGL) reported Non-Current Assets of $2.8 million for Q1 2026, down 23.96% year-over-year from $3.6 million in Q1 2025, and down 6.28% quarter-over-quarter from $2.9 million in Q4 2025.

Sol-Gel Technologies (SLGL) Non-Current Assets (2016 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has 11 years of Non-Current Assets data on file, last reported at $2.8 million in Q1 2026.

  • Non-Current Assets for Q1 2026 came in at $2.8 million, down 23.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.8 million (down 23.96% YoY), and the FY2025 annual result was $2.9 million, down 35.27% from the prior year.
  • Non-Current Assets declined to $2.8 million in Q1 2026 per SLGL's latest filing, from $2.9 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $9.3 million in Q1 2022 and troughed at $2.8 million in Q1 2026.
  • A 5-year average of $4.5 million and a median of $3.7 million in 2022 frame the typical range for Non-Current Assets.
  • On a YoY basis, Non-Current Assets climbed as much as 75.06% in 2022 and fell as far as 70.43% in 2022.
  • A 5-year view of Non-Current Assets shows it stood at $3.6 million in 2022, then advanced by 15.31% to $4.1 million in 2023, then climbed by 10.46% to $4.6 million in 2024, then plunged by 35.27% to $2.9 million in 2025, then declined by 6.28% to $2.8 million in 2026.
  • Business Quant data shows SLGL's Non-Current Assets at $2.8 million in Q1 2026, $2.9 million in Q4 2025, and $2.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 Sol-Gel Technologies 207.80 Mn 197.67 Mn - 2.76 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.76 Mn
Dec 31, 2025 2.95 Mn
Sep 30, 2025 2.94 Mn
Jun 30, 2025 3.05 Mn
Mar 31, 2025 3.63 Mn
Dec 31, 2024 4.55 Mn
Sep 30, 2024 5.03 Mn
Jun 30, 2024 3.72 Mn
Mar 31, 2024 3.90 Mn
Dec 31, 2023 4.12 Mn
Sep 30, 2023 4.39 Mn
Jun 30, 2023 3.51 Mn
Mar 31, 2023 8.36 Mn
Dec 31, 2022 3.57 Mn
Sep 30, 2022 3.73 Mn
Jun 30, 2022 6.51 Mn
Mar 31, 2022 9.34 Mn
Dec 31, 2021 12.08 Mn
Sep 30, 2021 4.68 Mn
Jun 30, 2021 5.01 Mn